NMU-23 Antibodies

Santa Cruz Biotechnology features a diverse variety of NMU-23 monoclonal antibodies for advanced research in the field of neurobiology. NMU-23 monoclonal antibodies demonstrate high effectiveness in various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Nociceptin/orphanin FQ (N/OFQ) is a neuropeptide that plays a crucial role in pain modulation, stress response, and various physiological processes. NMU-23 is involved in signaling pathways that affect mood, anxiety, and nociception, making it a significant target for research in pain management and neuropsychiatric disorders. Understanding NMU-23 function is essential for developing therapeutic strategies aimed at treating conditions related to the nervous system. Researchers worldwide rely on NMU-23 monoclonal antibodies to advance their understanding of neuropeptide signaling mechanisms. Current investigations focus on revealing new insights about NMU-23's role in neural pathways and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to neuroscience research and therapeutic development.